MELBOURNE, , Jan. 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic ...
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from ...
Kunitz and Northrop1 found the isoelectric point of crystalline chymotrypsinogen to be near pH 5 by their method of microcataphoresis2. Recently, Anderson and Alberty3 and Laskowski4, using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results